Orexigen, Valeant Pharmaceuticals deal

Orexigen’s Orexigen Therapeutics Ireland Ltd. subsidiary granted Valeant’s Valeant Holdings Ireland subsidiary rights to obesity drug Mysimba naltrexone/bupropion in 19 countries in and around Europe. The deal covers Greece, Slovenia, Slovakia, Czech Republic, Hungary, Croatia, Lithuania, Estonia, Poland, Latvia, Bulgaria, Romania, Serbia, Bosnia and Herzegovina, Albania, Macedonia, Montenegro, Kosovo and Turkey. ...